Real-world long-term safety and effectiveness of turoctocog alfa in the treatment of haemophilia A in Japan: results from a multicentre, non-interventional, post-marketing study

Real-world long-term safety and effectiveness of turoctocog alfa in the treatment of haemophilia A in Japan: results from a multicentre, non-interventional, post-marketing study

Objectives To assess the safety and effectiveness of turoctocog alfa in previously treated patients (PTPs) and previously untreated patients (PUPs) with haemophilia A in a real-world setting in Japan.Methods This multicentre, non-interventional, post-marketing study recruited patients with haemophil...

Full description

Saved in:
Bibliographic Details
Main Authors: Azusa Nagao, Ayumi Deguchi, Keiji Nogami
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Hematology
Subjects:
Factor VIII
Haemophilia A
Japan
inhibitors
prophylaxis
post-marketing product surveillance
Online Access:https://www.tandfonline.com/doi/10.1080/16078454.2024.2316540
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/16078454.2024.2316540

Similar Items